Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
Journal of Clinical Medicine · 13.07.2023 · 12 (14) · 4656
DOI: 10.3390/jcm12144656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.07.2023. Verfasst von Evangelos Katsarogiannis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Neurology, Uppsala University, SE-751 85 Uppsala, Sweden. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Uppsala (ALF).
Abstract (Originalsprache)
Background
Immunoglobulin gamma (IgG) oligoclonal bands (OCB) in the cerebrospinal fluid (CSF) are absent in a small group of multiple sclerosis (MS) patients. According to previous research, OCB-negative MS patients differ genetically but not clinically from OCB-positive MS patients. However, whether OCB-negative MS is a unique immunological and clinical entity remains unclear. The absence of OCB poses a significant challenge in diagnosing MS. (1)
Objective
The objective of this study was twofold: (1) to determine the prevalence of OCB-negative MS patients in the Uppsala region, and (2) to assess the frequency of misdiagnosis in this patient group. (2)
Methods
We conducted a retrospective study using data from the Swedish MS registry (SMSreg) covering 83% of prevalent MS cases up to 20 June 2020 to identify all MS patients in the Uppsala region. Subsequently, we collected relevant information from the medical records of all OCB-negative MS cases, including age of onset, gender, presenting symptoms, MRI features, phenotype, Expanded Disability Status Scale (EDSS) scores, and disease-modifying therapies (DMTs). (3)
Results
Out of 759 MS patients identified, 69 had an OCB-negative MS diagnosis. Upon re-evaluation, 46 patients had a typical history and MRI findings of MS, while 23 had unusual clinical and/or radiologic features. An alternative diagnosis was established for the latter group, confirming the incorrectness of the initial MS diagnosis. The average EDSS score was 2.0 points higher in the MS group than in the non-MS group (p = 0.001). The overall misdiagnosis rate in the cohort was 33%, with 22% of misdiagnosed patients having received DMTs. (4)
Conclusions
Our results confirm that the absence of OCB in the CSF should raise suspicion of possible misdiagnosis in MS patients and prompt a diagnostic reassessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Neurology, Uppsala University, SE-751 85 Uppsala, Sweden.
- Department of Surgical Sciences, Neuroradiology, Uppsala University, SE-751 85 Uppsala, Sweden.
ORCID-Profile: Anne-Marie Landtblom, Johan Wikström, Shala G Berntsson
Förderung
- Region Uppsala (ALF)
Zitieren
APA
Katsarogiannis, E., Landtblom, A. M., Kristoffersson, A., Wikström, J., Semnic, R., & Berntsson, S. G. (2023). Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis. Journal of Clinical Medicine, 12(14), 4656. https://doi.org/10.3390/jcm12144656
Vancouver
Katsarogiannis E, Landtblom AM, Kristoffersson A, Wikström J, Semnic R, Berntsson SG. Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis. Journal of Clinical Medicine. 2023;12(14):4656. doi:10.3390/jcm12144656
BibTeX
@article{Katsarogiannis2023,
author = {Katsarogiannis, Evangelos and Landtblom, Anne-Marie and Kristoffersson, Anna and Wikström, Johan and Semnic, Robert and Berntsson, Shala G},
title = {Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {14},
pages = {4656},
doi = {10.3390/jcm12144656}
}
EUVIMED